High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events

It is unclear whether the ChAdOx1 nCov-19 vaccine can induce the development of anti-PF4 antibodies in vaccinated individuals who have not developed thrombosis. The aim of this prospective study was to evaluate the presence of antibodies against heparin/PF4 in adults who received a first dose of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Terpos, Evangelos, Politou, Marianna, Ntanasis-Stathopoulos, Ioannis, Karalis, Vangelis, Merkouri, Efrosyni, Fotiou, Despina, Gavriatopoulou, Maria, Malandrakis, Panagiotis, Kastritis, Efstathios, Trougakos, Ioannis P., Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309977/
https://www.ncbi.nlm.nih.gov/pubmed/34358129
http://dx.doi.org/10.3390/vaccines9070712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309977/
https://www.ncbi.nlm.nih.gov/pubmed/34358129
http://dx.doi.org/10.3390/vaccines9070712

Ejemplares similares